133 results
Page 4 of 7
424B3
qb9bcf8 4ftn9
15 Nov 22
Prospectus supplement
5:27pm
8-K
EX-99.1
sxo35tk4w
14 Nov 22
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
8:48am
DEFR14A
vq4ep hv46w1
10 Nov 22
Revised proxy
7:33pm
8-K
EX-99.1
kykbiehnb1hryrks9ri
8 Nov 22
Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG
9:13pm
DEF 14A
msby0
8 Nov 22
Definitive proxy
5:25pm
8-K
EX-99.1
uw2xi gf3pxipoft52
31 Oct 22
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
4:11pm
8-K
EX-99.1
majuzs
24 Oct 22
Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
8:00am
8-K
EX-10.1
f8sqoxr gj3u8zlv
24 Oct 22
Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
8:00am
8-K
EX-99.1
0yg0q2j
14 Oct 22
Entry into a Material Definitive Agreement
8:54am
8-A12B
EX-4.1
ri400 qrwxnpceafqi8m
14 Oct 22
Registration of securities on exchange
8:07am
8-K
EX-99.1
u40mf2wuhz l5th5c0w4
5 Oct 22
Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
5:10pm
DRS
hjbuqr
29 Aug 22
Draft registration statement
12:00am
8-K
EX-99.1
ndw1ow
12 Aug 22
Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business Update
9:03am
8-K
EX-99.1
fkms a0ing6q
27 Jul 22
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
9:44pm
8-K
EX-99.1
nha80uh599wnl6
12 Jul 22
Biofrontera Inc. Announces Preliminary Product Revenues for the Second
4:13pm
424B3
uxnueb ha
9 Jun 22
Prospectus supplement
5:28pm